Amebiasis: Clinical Trials

4 trials for Amebiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4

Follow Amebiasis: new trials by email Literature Review of Amebiasis trials Research Report on Amebiasis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction
Moxifloxacin Ophthalmic, Chlorhexidine Gluconate, Natamycin - Acanthamoeba Keratitis, Fungal Keratitis
Phase 3CompletedUniversity of California, San Francisco3302022-08-032026-09-03
Polihexanide (PHMB) Eye Drops in Patients Affected by Acanthamoeba Keratitis
PHMB 0.08%, Propamidine 0.1%, placebo - Acanthamoeba Keratitis
Phase 3CompletedSIFI SpA1352017-08-132023-08-22
Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents
Nitazoxanide - Amebiasis
Phase 3CompletedRomark Laboratories L.C.502004-02-012006-08-21
Study of Nitazoxanide in the Treatment of Amebiasis in Children
Nitazoxanide - Amebiasis
Phase 3CompletedRomark Laboratories L.C.502004-02-012006-08-21

Narrower conditions

Acanthamoeba Keratitis (2)

Broader conditions

Infections (4)  ·  Parasitic Diseases (4)  ·  Protozoan Infections (4)  ·  Corneal Diseases (2)  ·  Eye Diseases (2)  ·  Eye Infections (2)  ·  Eye Infections, Parasitic (2)  ·  Keratitis (2)

Interventions

nitazoxanide (2)  ·  Corneal Cross-Linking (1)  ·  Natamycin (1)  ·  Rose Bengal (1)  ·  chlorhexidine gluconate (1)  ·  dibrompropamidine (1)  ·  polihexanide (1)

Sponsors

Romark Laboratories L.C. (2)  ·  SIFI SpA (1)  ·  University of California, San Francisco (1)

Countries

Egypt (2)  ·  Brazil (1)  ·  India (1)  ·  Italy (1)  ·  Poland (1)  ·  United Kingdom (1)

Top investigators

Samir M Kabil, MD (2)  ·  Yehia El-Gohary, MD (2)  ·  Jennifer Rose-Nussbaumer, MD (1)  ·  John Dart, MD (1)  ·  Nicole Varnado, MPH (1)  ·  Tom Lietman, MD (1)

Results publications

PMID 37802392, PMID 39011096, PMID 39192339, PMID 41561665, PMID 42348235

NIH funding

UG1EY028518 (1)